GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW 1,191.00
+14.00 (1.19%)
Last updated: May 28, 2026, 2:12 PM KST
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 106.99 billion as of May 28, 2026. Its market cap has decreased by -39.22% in one year.
Market Cap
106.99B
Enterprise Value
135.42B
Revenue
17.12B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,191.00
Market Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 106.99B, an increase of 3,046.90%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 106.99B | -35.90% |
| Dec 30, 2025 | 166.91B | -1.14% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1.25T | 30.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 189.88B |
| Macrogen | 152.86B |
| Vaxcell-Bio Therapeutics | 149.78B |
| MedPacto | 140.36B |
| ENCell | 133.12B |
| Amicogen | 128.30B |
| iNtRON Biotechnology | 95.79B |
| Prestige BioPharma | 93.75B |